Transcranial doppler quantification of residual shunt after percutaneous patent foramen ovale closure: Efficacy of the GORE A® HELEX septal occluder

Journal of Interventional Cardiology

Volumn 24, Issue 4, 2011, Pages 366-372

  Sorensen, Sherman G ^a,b   Smout, Randall ^c   Spruance, Spotswood L ^a  

^a Great Basin Cardiovascular Research Foundation Inc   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c INSTITUTE FOR CLINICAL OUTCOMES RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANEURYSM; ARTICLE; ATRIAL SEPTAL ANEURYSM; DOPPLER ECHOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HEART RIGHT LEFT SHUNT; HUMAN; INTRACARDIAC ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PATENT FORAMEN OVALE; PRIORITY JOURNAL; SEPTAL OCCLUDER; SHUNTING; TREATMENT FAILURE; VALSALVA MANEUVER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; FORAMEN OVALE, PATENT; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; SEPTAL OCCLUDER DEVICE; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; YOUNG ADULT;

EID: 80051492335     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2011.00644.x     Document Type: Article

References (23)

1. Woods TD, Patel A,. A critical review of patent foramen ovale detection using saline contrast echocardiography: When bubbles lie. J Am Soc Echocardiogr 2006; 19: 215-222. (Pubitemid 43187166)
2. Spencer MP, Moehring MA, Jesurum J, et al,. Power M-mode transcranial doppler for diagnosis of patent foramen ovale and assessing transcatheter closure. J Neuroimaging 2004; 14: 342-349. (Pubitemid 39331618)
3. Lao AY, Sharma VK, Tsivgoulis G, et al,. Detection of right-to-left shunts: Comparison between the international consensus and Spencer logarithmic scale criteria. J Neuroimaging 2008; 18: 402-406.
4. Sorensen SG, Aguilar H, McKnight WK, et al,. Transcranial Doppler quantification of residual shunt after percutaneous patent foramen ovale closure. Comparison of two devices. J Interv Cardiol 2010; 23: 575-580.
5. Blom NA, Ottenkamp J, Jongeneel TH, et al,. Morphogenetic differences of secundum atrial septal defects. Pediatr Cardiol 2005; 26: 338-343. (Pubitemid 43004574)
6. Spence MS, Khan AA, Mullen MJ,. Balloon assessment of patent foramen ovale morphology and the modification of tunnels using a balloon detunnelisation technique. Catheter Cardiovasc Interv 2008; 71: 222-228. (Pubitemid 351293769)
7. Porter CJ, Edwards WD,. Atrial septal defects. In, Allen HD, Driscoll DJ, Shaddy RE, Feltes TF, eds. Moss and Adams' Heart Disease in Infants, Children, and Adolescents: Including Fetus and Young Adult. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2008, pp. 632-642.
8. Chintala K, Turner DR, Leaman S, et al,. Use of balloon pull-through technique to assist in CardioSEAL device closure of patent foramen ovale. Catheter Cardiovasc Interv 2003; 60: 101-106. (Pubitemid 37071473)
9. Sorensen SG, Aguilar H, Reichert W, et al,. Transient neurological symptoms during contrast transcranial Doppler right-to-left shunt testing in patients with cryptogenic neurological disease. J Interv Cardiol 2010; 23: 284-290.
10. Meier B,. Stroke and migraine: A cardiologist's headache. Heart 2009; 95: 595-602.
11. Wahl A, Tai T, Praz F, et al,. Late results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the Amplatzer PFO occluder without intraprocedural echocardiography: Effect of device size. JACC Cardiovasc Interv 2009; 2: 116-123.
12. Windecker S, Wahl A, Nedeltchev K, et al,. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004; 44: 750-758. (Pubitemid 39099567)
13. von Bardeleben RS, Richter C, Otto J, et al,. Long term follow-up after percutaneous closure of PFO in 357 patients with paradoxical embolism: Difference in occlusion systems and influence of atrial septum aneurysm. Int J Cardiol 2009; 134: 33-41.
14. De Castro S, Cartoni D, Fiorelli M, et al,. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 2000; 31: 2407-2413.
15. Giardini A, Donti A, Formigari R, et al,. Spontaneous large right-to-left shunt and migraine headache with aura are risk factors for recurrent stroke in patients with a patent foramen ovale. Int J Cardiol 2007; 120: 357-362. (Pubitemid 47069562)
16. Cartoni D, De Castro S, Valente G, et al,. Identification of professional scuba divers with patent foramen ovale at risk for decompression illness. Am J Cardiol 2004; 94: 270-273. (Pubitemid 38902891)
17. Mas JL, Arquizan C, Lamy C, et al,. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001; 345: 1740-1746.
18. Lamy C, Giannesini C, Zuber M, et al,. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: The PFO-ASA Study. Atrial Septal Aneurysm. Stroke 2002; 33: 706-711. (Pubitemid 34203994)
19. Taaffe M, Fischer E, Baranowski A, et al,. Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder). Am J Cardiol 2008; 101: 1353-1358.
20. Harms V, Reisman M, Fuller CJ, et al,. Outcomes after trans-catheter closure of patent foramen ovale in patients with paradoxical embolism. Am J Cardiol 2007; 99: 1312-1315. (Pubitemid 46659874)
21. Bogousslavsky J, Garazi S, Jeanrenaud X, et al,. Stroke recurrence in patients with patent foramen ovale: The Lausanne study. Lausanne stroke with paradoxal embolism study group. Neurology 1996; 46: 1301-1305. (Pubitemid 26159291)
22. Jesurum JT, Fuller CJ, Renz J, et al,. Diagnosis of secondary source of right-to-left shunt with balloon occlusion of patent foramen ovale and power M-mode transcranial doppler. JACC Cardiovasc Interv 2009; 2: 561-567.
23. Furlan AJ,. A prospective, randomized controlled trial to evaluate the safety and efficacy of the STARFlex Septal Closure System vs. medical therapy in patients with a stroke or transient ischemic attack due to presumed paradoxical embolism through a PFO. Circulation 2010;122 [21/supplement][presentation].